Literature DB >> 32251649

Coronavirus disease 2019 pandemic: staged management of surgical services for gynecology and obstetrics.

Emily E Weber LeBrun1, Nash S Moawad2, Eric I Rosenberg3, Timothy E Morey4, Laurie Davies4, William O Collins5, John C Smulian2.   

Abstract

The coronavirus disease 2019 pandemic warrants an unprecedented global healthcare response requiring maintenance of existing hospital-based services while simultaneously preparing for high-acuity care for infected and sick individuals. Hospitals must protect patients and the diverse healthcare workforce by conserving personal protective equipment and redeployment of facility resources. While each hospital or health system must evaluate their own capabilities and surge capacity, we present principles of management of surgical services during a health emergency and provide specific guidance to help with decision making. We review the limited evidence from past hospital and community responses to various health emergencies and focus on systematic methods for adjusting surgical services to create capacity, addressing the specific risks of coronavirus disease 2019. Successful strategies for tiered reduction of surgical cases involve multidisciplinary engagement of the entire healthcare system and use of a structured risk-assessment categorization scheme that can be applied across the institution. Our institution developed and operationalized this approach over 3 working days, indicating that immediate implementation is feasible in response to an unforeseen healthcare emergency.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; case cancellations; coronavirus; emergency response; gynecology; obstetrics; staged management; surgery; surgical subspecialties

Mesh:

Year:  2020        PMID: 32251649      PMCID: PMC7194667          DOI: 10.1016/j.ajog.2020.03.038

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   10.693


The global, national, and local healthcare response to the novel coronavirus disease 2019 (COVID-19) provides an opportunity to share best practices for managing surgical services during a health-related crisis. A response to any health emergency must be tailored to the specific threat, be it infectious (such as COVID-19 or influenza), a natural weather event, bioterrorism, or an active shooter. The role of surgical services in a health-related emergency is important and has potentially modifiable components related to healthcare delivery. Variables to be considered when determining how surgical services might be adjusted must factor in the anticipated impact and duration of the event, the reliance on perioperative and institutional resources, and the impact of adjusting routine operations on both affected and unaffected patient populations. Decisions regarding the cancellation, postponement, and prioritization of surgical services are frequently dictated by the specific threat, but the timing of making changes can present the most difficult challenge. Importantly, the principles that guide decisions are similar regardless of the emergency. We present principles of management of surgical services during a health emergency and provide specific guidance to help with decision making to help institutions or clinical practices considering changes to surgical services because of the COVID-19 pandemic.

Planning considerations

The World Health Organization (WHO) provides an all-hazards list of key actions to be considered by hospitals in response to any disaster event. This tool provides guidance on establishing a command center, consistent and effective communication, prioritization of safety and security, the logistics of triage and supply management in light of surge capacity while maintaining essential services, and postdisaster recovery planning. In 2014, the WHO hospital emergency response checklist was used as an evaluation tool kit in a cross-sectional study to assess the preparedness of 15 hospitals in Italy. It showed that most had adequate command and control response operations but had insufficient communication systems for potential disaster. Although there is some correlation between the level of hospital care and preparedness, there was a poor level of readiness to implement strategic and logistical plans. In fact, some hospitals successfully anticipated infrastructure needs, such as water, sanitation, and electricity, but failed to demonstrate a coordinated and strategic plan for surge capacity. Inpatient surge capacity is the ability to generate staffed beds in response to a surge in demand for inpatient healthcare services. In times of emergent increase in healthcare demand, the goal is to increase capacity between 10% and 20%, although the target may vary based on specific circumstances. , Financial demands have traditionally prompted hospitals to maintain a high inpatient census to meet tighter budgets. Naturally, this limits their ability to respond to a sudden large surge in demand over the typical occupancy of 90%–95%. This is particularly true for times of high occupancy during natural surge cycles as can be seen with the influenza or respiratory syncytial virus. These large (sometimes academic), nonprofit, and safety-net hospitals with level I trauma centers depend on the financial security of maintaining a high patient census and large surgical volumes. These sites will also be relied on for expertise in caring for nonsurgical patients with critical illness resulting from an emerging pathogen, in addition to the ongoing demands of high-level surgical services.

Adjustment of surgical services

Despite these conflicts, 1 strategy to free up capacity within a hospital system is through cancellation of nonessential surgical cases that most commonly occurs in an unstructured and decentralized manner. As seen previously, nonsystematic modifications of procedural schedules and adjusting admission and discharges were shown to reduce occupancy and demand of nonurgent hospital resources after the New York attacks in 2001 and after the severe acute respiratory syndrome Toronto outbreak in 2003 by 9% and 12%, respectively. In 2016, researchers reported a structured system of categorizing surgical procedures based on the potential impact on inpatient surge capacity if a procedure was to be canceled or delayed. Using chart review, all planned procedures over a 4-week period (n=2821) were categorized based on their impact on inpatient capacity and the safety of their delay into 1 of 4 groups: (A) procedures with no impact on inpatient capacity, (B) procedures that could be delayed indefinitely, (C) procedures that could be delayed by 1 week, and (D) procedures that could not be delayed. This strategy of delaying scheduled cases in categories B and C most effectively (especially on Mondays) led to a reduction of inpatient occupancy by 8% (65 beds). Although category A cases, such as outpatient procedures and same-day procedures, do not impact inpatient occupancy, they do require other equipment and staffing resources, thus limiting potential surge capacity during a healthcare crisis requiring intensive patient care. An important element of managing surgical services in the setting of a healthcare emergency is planned coordination throughout the hospital system, including various surgical departments, anesthesia, and nursing services. In the current COVID-19 crisis, the American College of Surgeons issued the following recommendation: “Each health system and surgeon should thoughtfully review all scheduled elective procedures with a plan to minimize, postpone or cancel elective [cases] until we can be confident that our health care infrastructure can support [an increase] in critical patient care needs.” A joint statement from leading societies in gynecologic surgery and the US Surgeon General encouraged hospitals to consider modifying surgical scheduling in areas where COVID-19 is prevalent. , Effective rescheduling of surgeries should involve engagement of the entire hospital system with specific attention to the unique demands of the crisis at hand. Also of importance, many surgeries are performed in settings outside of hospital systems through either free-standing outpatient surgical centers or clinical offices. These entities are usually excluded from planning considerations since they are often removed, both operationally and financially, from the larger hospital systems. This creates a potential conflict of interest when making decisions about surgery reductions. Communication during a healthcare emergency is critical, and differences in the management of elective cases can interfere with consistent messaging across an institution and to the public. Community practices and nonaffiliated surgical facilities should be included in this process and have similar expectations for adjusting care. In the event of widespread COVID-19 infection, all resources may be severely strained and should be conserved to care for life-threatening infections rather than elective surgical procedures. The wide spectrum of clinical manifestations seen in COVID-19 complicates predictions of the impact on healthcare. Therefore, it is difficult to anticipate when the epidemic will peak and introduce further difficulty in the detection of cases. Current data suggest that the risk for developing acute respiratory distress syndrome (ARDS, 17%–29%) and death (1%) are most commonly seen in the elderly (older than 70 years) and those with underlying respiratory illness. Clinically recognized infection in children seems less frequent (2%), and limited data suggest that pregnant women are not particularly vulnerable to contracting the illness and have similar maternal complications to other populations. There appears to be an increased risk for preterm birth, fetal distress, and cesarean delivery with infection. Nevertheless, 1:1 obstetric and pediatric staffing and the resultant personal protective equipment (PPE) needs offer additional strains on resources.

Gynecologic and obstetric surgery

Preparing for COVID-19 community spread requires emergency response planning as outlined by the WHO. Additional preparedness actions can be elucidated from the Italian experience, which provides guidance on forecasting ICU surge capacity and promoting containment measures once the outbreak has begun. However, there is little guidance for managing scheduled, elective surgical services while awaiting the onslaught of COVID-19 cases. While hospital leadership is engaged in logistical planning, the maintenance of some limited surgical services may provide a financial balance to hospitals and allow physicians and staff to remain focused on providing high-quality care. Utilizing the principles from Soremekun et al, it is possible to develop specialty-specific case categories and establish a schedule for tiered, coordinated case cancellation/postponement. Table 1 shows the staged reduction considerations for gynecologic and obstetric surgeries used at the University of Florida to guide decision making. Category I includes elective cases of any type performed on a patient at high risk of complications associated with COVID-19 infection. In the setting of COVID-19, category I was designed to identify all patients across all services whose mere presence in a densely populated hospital with COVID-19 community transmission would pose a greater risk to the patient than to postpone their surgery. For example, urogynecology largely serves older patients who are also at high risk of morbidity and mortality resulting from COVID-19 infection but whose surgical treatment can usually be delayed for patient protection.
Table 1

General guidance to assist gynecologists and obstetricians with staged cancellation or postponement of surgical cases in response to the COVID-19 pandemic. Individual case-specific characteristics may modify category assignment for a given patient

Category:IIIIIIIVV
Trigger(s) to cancel or delay

Community transmission

Community transmission

Inpatient bed availability limited

PPE supply limited

Community transmission

Inpatient bed availability limited

Case-by-case basis with team review

Community transmission

PPE supply limited

Never canceled
COVID-19 morbidity and mortality riskHighVulnerable populationAverageAverageAverageAll risk levels
Urgency levelLowLowModerate (can delay up to 14 d)LowHigh
Impact on bed capacityVariable by procedure (possible inpatient)Variable by procedure (possible inpatient)Variable by procedure (possible inpatient)No impact (same-day surgery)High (inpatient, emergency department)
Examples of patient characteristics and/or surgical case types
Benign gynecologyFor all surgical groups

Immunocompromised

Elderly (older than 70 y)

Respiratory disease

Other comorbidities

Excision of pelvic masses without high suspicion of malignancy

Hysterectomy for benign disease

Major minimally invasive surgery (excision of advanced endometriosis or adhesions)

Excision of benign mass affecting health (causing ureteral obstruction)

Missed abortion

Interval tubal ligation

Hysteroscopy

D&C

Minor adnexal surgery

Minor laparoscopy

Minor vaginal surgery

Ectopic pregnancy

Ovarian torsion

Tuboovarian abscess requiring surgery

Uncontrollable uterine bleeding; no cancer

Incomplete abortion

Urogynecology

Hysterectomy (with overnight stay)

Major pelvic floor repairs

Sacral colpopexy

Mass resulting in urinary obstruction

Minor pelvic floor repairs

Minimally invasive surgery

Hysterectomy (same-day discharge)

Irreducible procidentia resulting in acute urinary retention

Gynecologic oncology

Hysterectomy for complex benign disease

Prophylactic surgery heritable cancer risk

Cysts followed for long periods without change and negative serum markers (Benign Gyn or Gyn Onc)

Excision of malignant mass

Hysterectomy for early endometrial cancer

Surgery for preinvasive disease: EIN, VIN, VAIN, CIN

Bowel obstruction

Uncontrollable uterine bleeding from cancer

Pelvic mass causing severe symptoms

Reproductive endocrinology and infertility

Abdominal myomectomy

N/A

Hysteroscopy, D&C

Septoplasty

Adnexal surgery

Minor laparoscopy

IVF retrievals and transfers

IUIs and office procedures

Ectopic pregnancy

Ovarian torsion

Treatment of ovarian hyperstimulation

Obstetrics

Considered a vulnerable population and should only have indicated procedures to preserve maternal and fetal health

Delayed postpartum tubal ligation (separate anesthesia episode)

Ovarian cystectomy

Scheduled cesarean

Scheduled labor induction

History-indicated cerclage

Amniocentesis

Chorionic villous sampling

N/A

Emergent cesarean

Emergent cesarean hysterectomy

Rescue cerclage

Incarcerated uterus

Ovarian torsion

Intrauterine transfusion

Tubal ligation at cesarean or with delivery

CIN, cervical intraepithelial neoplasia; COVID-19, coronavirus disease 2019; D&C, dilation and curettage; EIN, endometrial intraepithelial neoplasia; IUI, intrauterine insemination; IVF, in vitro fertilization; N/A, not applicable; PPE, personal protective equipment; VIN, vulvar intraepithelial neoplasia; VAIN, vaginal intraepithelial neoplasia.

Weber LeBrun. COVID-19 pandemic: staged management of surgical services for gynecology and obstetrics. Am J Obstet Gynecol 2020.

General guidance to assist gynecologists and obstetricians with staged cancellation or postponement of surgical cases in response to the COVID-19 pandemic. Individual case-specific characteristics may modify category assignment for a given patient Community transmission Community transmission Inpatient bed availability limited PPE supply limited Community transmission Inpatient bed availability limited Case-by-case basis with team review Community transmission PPE supply limited Immunocompromised Elderly (older than 70 y) Respiratory disease Other comorbidities Excision of pelvic masses without high suspicion of malignancy Hysterectomy for benign disease Major minimally invasive surgery (excision of advanced endometriosis or adhesions) Excision of benign mass affecting health (causing ureteral obstruction) Missed abortion Interval tubal ligation Hysteroscopy D&C Minor adnexal surgery Minor laparoscopy Minor vaginal surgery Ectopic pregnancy Ovarian torsion Tuboovarian abscess requiring surgery Uncontrollable uterine bleeding; no cancer Incomplete abortion Hysterectomy (with overnight stay) Major pelvic floor repairs Sacral colpopexy Mass resulting in urinary obstruction Minor pelvic floor repairs Minimally invasive surgery Hysterectomy (same-day discharge) Irreducible procidentia resulting in acute urinary retention Hysterectomy for complex benign disease Prophylactic surgery heritable cancer risk Cysts followed for long periods without change and negative serum markers (Benign Gyn or Gyn Onc) Excision of malignant mass Hysterectomy for early endometrial cancer Surgery for preinvasive disease: EIN, VIN, VAIN, CIN Bowel obstruction Uncontrollable uterine bleeding from cancer Pelvic mass causing severe symptoms Abdominal myomectomy Hysteroscopy, D&C Septoplasty Adnexal surgery Minor laparoscopy IVF retrievals and transfers IUIs and office procedures Ectopic pregnancy Ovarian torsion Treatment of ovarian hyperstimulation Considered a vulnerable population and should only have indicated procedures to preserve maternal and fetal health Delayed postpartum tubal ligation (separate anesthesia episode) Ovarian cystectomy Scheduled cesarean Scheduled labor induction History-indicated cerclage Amniocentesis Chorionic villous sampling Emergent cesarean Emergent cesarean hysterectomy Rescue cerclage Incarcerated uterus Ovarian torsion Intrauterine transfusion Tubal ligation at cesarean or with delivery CIN, cervical intraepithelial neoplasia; COVID-19, coronavirus disease 2019; D&C, dilation and curettage; EIN, endometrial intraepithelial neoplasia; IUI, intrauterine insemination; IVF, in vitro fertilization; N/A, not applicable; PPE, personal protective equipment; VIN, vulvar intraepithelial neoplasia; VAIN, vaginal intraepithelial neoplasia. Weber LeBrun. COVID-19 pandemic: staged management of surgical services for gynecology and obstetrics. Am J Obstet Gynecol 2020. Categories II and IV are similar except for the postoperative hospital-care burden. Category II cases require overnight hospitalization or potential intensive care and can be postponed if the hospital resources are overstretched. In contrast, category IV cases occur in an off-site or independent ambulatory care center and therefore could continue without straining hospital-based resources (since some health systems do not maintain separate locations or surgical environments, categories II and IV may not be distinct for those centers). Although individuals in categories II and IV may be at lower risk for viral morbidity (such as most patients with benign and pediatric gynecology needs), consideration should be given to postponement if their surgery is nonessential and their potential exposure places the community at greater risk. In contrast, before the evidence of COVID-19 community spread, early completion of category IV cases will serve the low-risk population without expending significant resources and reduce additional hospital burden once the crisis resolves. Thus, both the specific community environment and COVID-19 risk must be considered. Category III describes urgent procedures (or cases) that need to be performed within the next 7–14 days, but which can be scheduled strategically on the basis of hospital resources. In the COVID-19 setting, terminal cleaning of an operating room, preparation of adequate PPE, or mobilization of staff may be prioritized to strategically delay a category III case. For example, surgical oncology cares for patients at the highest risk for contracting COVID-19 and, simultaneously, for experiencing devastating outcomes with a delay in cancer care. These cases best fit into category III, prompting a case review and individualized risk assessment. Finally, category V cases are emergent and should not be delayed for any reason. Emergent cases such as ovarian torsion and ectopic pregnancies fall into category V, for which a careful risk assessment is undertaken and the case performed urgently with mobilization of available resources. This categorization strategy depends heavily on surgeons to fairly identify several key factors about the patient and the planned surgery, to weigh the relative impacts of those factors on the overall health of the patient, and to seek peer review when confounding factors are involved. When considering symptomatic or COVID-19–positive surgical patients, we suggest that a multidisciplinary team must balance the various risks and benefits to the patient and to the entire healthcare system. There are a number of considerations for triggering a staged reduction in surgical services (Table 2 ). Nevertheless, for COVID-19, the emergence of local or regional community transmission is the most important. Because pregnancy care (antenatal, intrapartum, and postpartum) is not optional, it is particularly important to conserve and protect this highly specialized workforce and assigned PPE resources to safely ensure the ability to provide services during the outbreak. This may mean an earlier reduction of benign gynecologic surgeries than in other specialties.
Table 2

Selected considerations important for guiding decisions surrounding a staged reduction in surgical services during the COVID-19 pandemic

Public health concernsPatient concernsHealthcare system concerns

Extent of community transmission

Risk for mortality for nosocomial infection

Comorbidities confounding screening (eg, tracheostomy)

Urgency of surgical indication

Health impact(s) if procedure postponed/canceled

Availability of PPE, both general surgical masks and COVID-19–resistant air-purifying masks/head coverings

Availability of blood bank resources

Availability and health of surgical teams

Surgeon

Anesthesiologist

Specialty consultative clinicians

Surgical assistance

Nursing support

Custodial and sterile-processing staff

Room capacity

Operating suites with negative pressure capabilities

Preoperative areas

Postoperative areas

Inpatient rooms

Emergency department

COVID-19, coronavirus disease 2019; PPE, personal protection equipment.

Weber LeBrun. COVID-19 pandemic: staged management of surgical services for gynecology and obstetrics. Am J Obstet Gynecol 2020.

Selected considerations important for guiding decisions surrounding a staged reduction in surgical services during the COVID-19 pandemic Extent of community transmission Risk for mortality for nosocomial infection Comorbidities confounding screening (eg, tracheostomy) Urgency of surgical indication Health impact(s) if procedure postponed/canceled Availability of PPE, both general surgical masks and COVID-19–resistant air-purifying masks/head coverings Availability of blood bank resources Availability and health of surgical teams Surgeon Anesthesiologist Specialty consultative clinicians Surgical assistance Nursing support Custodial and sterile-processing staff Room capacity Operating suites with negative pressure capabilities Preoperative areas Postoperative areas Inpatient rooms Emergency department COVID-19, coronavirus disease 2019; PPE, personal protection equipment. Weber LeBrun. COVID-19 pandemic: staged management of surgical services for gynecology and obstetrics. Am J Obstet Gynecol 2020. Although each hospital or healthcare system must evaluate their own capabilities and surge capacity, this approach can be applied across all surgical departments allowing for a consistent and measured management of resources. We have provided an expanded table with additional categorized examples from other procedural specialties that might be useful for guiding decisions including general surgery, pediatric surgery, neurosurgery, otolaryngology, and psychiatry (Appendix).

Summary

The widespread COVID-19 epidemic in China showed a high rate of infection in healthcare personnel, up to 63% in Wuhan (1080 of 1716), with 14.8% cases classified as severe or critical (247 of 1668) and 5 deaths. , This can quickly overwhelm resources and make it very challenging to provide adequate care for ill COVID-19 patients. Minimizing all unnecessary patient contact through proactive systematic postponement of elective surgical cases and all nonessential outpatient visits is key to channeling all healthcare resources to overcoming this COVID-19 pandemic.
Supplementary Table

General guidance to assist surgeons and hospital leaders with staged cancellation or postponement of surgical cases in response to the COVID-19 pandemic. Individual case-specific characteristics may modify category assignment for a given patient. The surgical services available at any individual health center will vary. This table is intended as a guide and could be expanded or modified for use in any individual hospital

CategoryIIIIIIIVV
Trigger(s) to cancel or delay

Community transmission

Community transmission

Inpatient bed availability limited

PPE supply limited

Community transmission

Inpatient bed availability limited

Case-by-case basis with team review

Community transmission

PPE supply limited

Never canceled

COVID-19 morbidity and mortality riskHighAverageAverageAverageAll risk levels
Urgency levelLowLowModerate (can delay up to 14 d)LowHigh
Impact on bed capacityVariable by procedure (possible inpatient)Variable by procedure (possible inpatient)Variable by procedure (possible inpatient)No impact (same-day surgery)High (inpatient, emergency department)
Examples of patient characteristics and/or surgical case types
General surgeryFor all surgical groups

Immunocompromised

Elderly (older than 70 y)

Respiratory disease

Other comorbidities (as specifically listed)

Excision of benign mass

Joint replacement

Cosmetic procedures

Excision of malignant mass

Cardiac catheterization for stable angina

Fixation of closed orthopedic injury

Day-stay surgeries

Surgical centers

Procedures on patients already admitted, allowing for immediate discharge

Emergent trauma or acute abdomen (hemorrhage)

Required surgical intervention for infection

Spinal cord decompression

Transplants

Cardiac catheterization for acute myocardial infarction

Procedures on ICU patients (open abdomen, PEG, tracheostomy)

Burn surgery

Release of burn scar contractures in cases without impending functional compromise from contracture

Release of burn scar contractures in cases with impending functional compromise from contracture

Laser-based fractional ablation of hypertrophic scars

Scar revision and release of burn scar contractures (when deemed feasible as an outpatient surgery)

Excision/debridement, preparation, and coverage of burns or wound beds

Amputation

Tracheostomy for high-risk airways or to facilitate wound treatment

Breast, melanoma

Lymph node dissection

Total thyroidectomy/bilateral neck dissection

Mastectomy

Adrenalectomy

Excision of benign mass

Partial mastectomy

Parathyroidectomy

Thyroid lobectomy

Breast abscess

Sarcoma that has received radiation therapy

Colorectal

AIN/condyloma cases (impacts N95 mask supply)

Nonurgent benign anorectal cases requiring inpatient stay

Pelvic floor repair (rectal prolapse, etc)

Intestinal resection for cancer, diverticulitis, and inflammatory bowel disease

Nonurgent benign anorectal cases usually treated as outpatient (excluding AIN/condyloma)

Sacral nerve stimulator for incontinence

Colonoscopy

Urgent/emergent intestinal surgery for perforation or obstruction

Urgent/emergent anorectal cases: abscess, incarcerated prolapse, and necrotizing infections of the perineum

Minimally invasive

Antireflux procedures in lung transplant patients

Elective incisional hernia repair

Antireflux procedures

Bariatric procedures

Repair of symptomatic hernias

Cancer resection

Surgical procedures for severe nutritional depletion

Groin hernia repair

Endoscopy

Urgent/emergent intestinal surgery for perforation, obstruction

Pancreas, biliary

Symptomatic incisional hernia

Chronic pancreatitis

Pancreas cancer

Liver metastasis

Symptomatic incisional hernia

Biliary colic

Biliary pancreatitis

Patients with cancer receiving neoadjuvant therapy where surgical timing is driven by radiation treatment

Plastics

Reconstruction of existent, nonfunctional conditions: delayed breast reconstruction, chronic wounds, and facial palsy free flaps

Cleft palate surgery

Craniosynostosis

Breast reduction

Aesthetic/cosmetic surgery

Hand/upper extremity outpatient surgery

Lipomas and other outpatient skin/soft tissue benign tumors

Migraine surgery

Acute traumatic reconstruction: facial fractures, long-bone fractures, and acute soft tissue reconstruction

Reconstruction for acutely created cancer defects

Aggressive cutaneous cancer resections (melanoma, Merkel cell)

Vascular

Severe COPD

Elective venous cases interventions for claudication

Asymptomatic carotid procedures

<6 cm AAA

New hemodialysis access creation

CLI and ALI procedures

>6 cm AAA or TAAA

Symptomatic carotid

Ruptured or infected procedures (vascular surgery emergencies)

Aortic dissections

Acute mesenteric ischemia

Cardiac

CABG stable CADz

TAVR/valve nonurgent

TEVAR nonurgent

Aneurysm nonurgent

VAD

N/A

Acute aortic dissection

Transplants

Left main coronary artery disease/CABG

Post-MI VSD, Mitral

Thoracic

Surgical lung biopsy

Diaphragmatic plication

Decortication for stable trapped lung

Lung cancer surgery

Esophageal cancer surgery

Mediastinal tumor

Lung transplant patients awaiting at home or floor

Empyema thoracoscopy

N/A

Lung transplant patients admitted to TVICU

ECMO cannulation and initiation

Thymectomy on patients with unstable myasthenia

Congenital heart surgery

Elective heart defects

Chronic heart defects with -ASD, sinus venous ASD with PAPVR

Elective VSD in older patients

Some single ventricular patients

Some patients with shunt lesions

Single ventricles that are hypoxemic

Transplants

VADs for sick patients with heart failure

Infected endocarditis

Kids with acute heart failure

Infections requiring urgent surgery

Congenital heart cath

Transplant (surveillance cath)

Chronic lung disease

Trach/vent dependent

Other comorbidities involving CV/pulmonary system (mainly ACHD)

Elective device closures

Noncritical valve interventions and stents

Asymptomatic outpatient transcatheter valve implantation

Single ventricle cath patients

Transplant patients with concern for rejection

Symptomatic patients requiring valve intervention/ implantation, stent placement, or device closure

Routine diagnostic cath without planned intervention

Inpatient requiring urgent diagnostic cath or therapeutic intervention

Transplant patients with concerns for acute rejection

Congenital Heart EP

Transplant

Chronic lung disease

Trach/vent dependent

Other comorbidities involving CV/pulmonary systems (mainly ACHD)

Implantable loop recorder implant

Diagnostic EPS only

EPS/ablation of SVT

Pacemaker or ICD generator replacement

Device upgrade +/- extraction (elective)

EPS/ablation of VT

Pacemaker implant (new)

Primary prevention ICD implant

Ablation for unstable refractory arrhythmias

Infected device extraction

Secondary prevention ICD implant (postarrest)

Pediatric surgery

Cystic fibrosis

Respiratory illness/vent dependent

Large burns (immune issues)

Stoma reversals

Outpatient gastrostomy tubes (with temporary tube in place)

Congenital lung lesions

Benign masses

Outpatient cholecystectomy

Interval appendectomy

Neck masses (eg, thyroid)

Small burns (outpatient)

Bowel resections (nonobstructive)

Symptomatic gallbladder disease

Need for feeding access (especially inpatients to facilitate discharge)

Some malignancy-associated procedures (central access, resections)

Inguinal hernia repair

Orchiopexy

Circumcision

Umbilical hernia

Integumentary surgery (skin lesions, nail lesions, etc)

EGD/colonoscopy

Breast masses

Neck masses (superficial)

Awaiting surgery for discharge (hernia, g-tube, etc)

All emergent procedures (eg, appendicitis, cholecystitis, trauma, burn debridement, bowel obstructions, GI bleeding)

Malignancies requiring biopsy or resection to start therapy

Empyema not responding to medical management

Newborn surgical procedures

ECMO

Incarcerated hernia

Esophageal/airway foreign bodies

Gonadal torsion (testicular, ovarian)

Abdominal transplant surgery

Elderly (older than 70 y) – unless need for urgent dialysis access

Pancreas transplants

Excision of benign mass

Excision of some malignant masses

Living donor kidney transplants (being delayed until at least April 28, 2020, as of March, 17, 2020; will then be reassessed)

Day-stay surgeries

Procedures on patients already admitted, allowing for immediate discharge

Acute abdomen or surgical equivalent

Required surgical intervention for infection

Liver transplants MELD over 25 years old or ill

Detailed acceptance criteria for deceased donor kidney transplants created based on both recipient and donor graft risk criteria

Excision of some malignant masses

NeurosurgeryVascular

Any open surgical or endovascular elective aneurysm, any open surgical or endovascular elective AVM

Open surgical elective aneurysm, open surgical elective AVM, open surgical carotid in patient of any age

Endovascular elective aneurysm, endovascular elective AVM, endovascular elective carotid in patient of any age

Diagnostic cerebral angiograms

Ruptured aneurysm, ruptured AVM, acute stroke, ICH

NeurosurgerySpine

Elective degenerative spine surgery without motor deficit, or stable motor deficit >3 mo

Resection of benign spinal mass, for example, meningioma, schwannoma without motor deficit or stable motor deficit >3 mo

Spinal instability that can be managed indefinitely with a brace

Elective spinal procedure requiring multilevel spinal instrumentation (cervical, thoracic, or lumbar)

Spinal condition with a stable motor deficit >72 h

Any spinal condition that is not emergent but requires inpatient management until definitively treated (eg, unstable thoracic fracture on bed rest until surgery)

Malignant primary or secondary spinal tumor

Progressive cervical or thoracic myelopathy, spine tumor without deficit but cord compression

Level 1 or 2 lumbar decompression

Level 1 anterior cervical surgery or level 1–2 posterior cervical decompression

Single level ACDF, microdiscectomy, single level laminectomy

Spinal cord/ nerve compression or spinal instability with <72 h motor deficit or progressive motor deficit within 72 h

Spine fracture, spine pathology with an acute severe neurologic deficit (ie, tumor, abscess/osteo, cauda equina)

NeurosurgeryStereotactic/radiosurgery/brain tumors, trigeminal neuralgia

Benign, minimally symptomatic tumor

Benign brain tumors, elective cervical/lumbar stenosis cases

Benign minimally symptomatic tumor of any age

MVD cases where patients are in a lot of pain, symptomatic benign posterior fossa lesions

Benign tumor of any age with moderate neurologic symptoms

Outpatient radiosurgery and RFL cases

Malignant brain tumor of any age

Intracranial bleeding, symptomatic large brain tumors, symptomatic spinal cord lesions, trauma

Hospitalized benign brain tumor patient with significant neurologic symptoms or hospitalized malignant brain tumor

Pediatric neurosurgery

Respiratory illness/vent dependent

Chiari decompression (most)

Cranioplasty for skull dehiscence or contour

Craniotomy for epilepsy focus, nontumor

Vagus nerve stimulator new implant

Baclofen pump new implant

Dorsal rhizotomy

Stereo EEG

Scoliosis or other spinal deformity repair (1- to 3-mo delay)

Cranioplasty after decompressive craniectomy

Craniosynostosis (most)

Spinal cord detethering (most)

Cranial/spinal tumor biopsies/resections (most)

Discectomy/laminectomy without acute neurodeficit

Pseudomeningocele repair (most)

Moyamoya bypass

Baclofen pump replacement

Scalp dermoid

Cranial spring removal

Muscle/nerve biopsy

Vagus nerve stimulator battery replacement

Shunt placement/revision

Spinal instability/trauma

Endoscopic hydrocephalus surgery

Evacuation of intracranial/intraspinal hematoma or empyema

Myelomeningocele closure

Congenital encephalocele repair

CSF leak repair

Discectomy/laminectomy with acute neurodeficit

Decompressive craniectomy

Repair of open or depressed skull fracture

Other urgent or emergent cases as dictated by patient status

Neurosurgery, epilepsy surgery, pituitary tumors

Any elective epilepsy or pituitary case in patient aged 70 y or older or with pulmonary disease

RNS for epilepsy, transsphenoidal surgery for pituitary tumor, stereo EEG for epilepsy, anterior temporal lobectomy for epilepsy

VP shunt for pseudotumor pituitary tumor with visual field defect

Sural nerve biopsy

VNS placement and VNS generator change

Transsphenoidal surgery for pituitary apoplexy

Neurosurgery, DBSAny elective DBS or battery change procedure in patient 70 years or older, immunocompromised, or with respiratory diseaseElective DBS surgery in patients <70 years oldBattery change procedures in patients <70 years oldInfected DBS or infected battery
Otolaryngology

Immunocompromised

Elderly (older than 70 y)

Chronic respiratory disease

Cystic fibrosis

Elective aerosol-generating procedures, such as endoscopy, bronchoscopy

Tracheotomy dependent

Most tonsil/adenoid removals

Benign thyroid and parotid masses

Tympanoplasties and mastoidectomies

Cochlear implants

Chronic inflammatory endoscopic sinus surgery

Septorhinoplasty

Malignancy of upper aerodigestive tract or salivary glands

CSF leaks

Sinonasal tumors

Facial trauma

Laryngotracheal stenosis, especially if not tracheostomized

∗These cases could wait a short duration, but not >3–4 wk

Cases occurred at an ambulatory surgical center

Emergent airway

Neck abscesses

Orbital or intracranial complications of otitis media or sinusitis

Invasive fungal sinusitis

Psychiatry, ECT

Immunocompromised

Elderly (older than 70 y)

Respiratory disease

Cardiac disease

Other comorbidity

Maintenance ECT for prevention of relapse

Post-ECT taper

Nonsuicidal in ECT treatment series

High acuity in mid-ECT series

Catatonia with severe malnourishment

Suicidal inpatients in mid-ECT series

Trauma orthopedics-

Malunion

Some nonunion with intact hardware

Posttraumatic fusion/arthroplasty

Some fractures

Minor hardware removal

Manipulation under anesthesia

Some fractures

Acute fractures

Infection

Polytrauma

Foot and ankle-

Mostly elective

Below-knee amputation

Most Charcot reconstruction

Ankle replacements or similar reconstruction

Some elective partial foot amputation

Some elective below-knee amputation

Mostly elective sports, arthritis, outpatient trauma, reconstructive foot and ankle surgery

All digit amputations

Acute or acute on chronic infections

Polytrauma with foot fracture as main orthopedic injury

Orthopedic, spine

Elective degenerative spine surgery without motor deficit, or stable motor deficit >3 mo

Resection of benign spinal mass without motor deficit or stable motor deficit >3 mo

Spinal instability that can be managed indefinitely with a brace.

Spinal condition with a stable motor deficit >72 h

Malignant primary or secondary spinal tumor

Any spinal condition that is not emergent but requires inpatient management until definitively treated (eg, unstable thoracic fracture)

Level 1 or 2 lumbar decompression or microdiscectomy

Level 1 anterior cervical surgery

Level 1–2 posterior cervical decompression

Spinal cord/nerve compression or spinal instability with <72 h motor deficit or progressive motor deficit within 72 h

Orthopedic oncology

Benign bone

Benign soft tissue

Hardware removal

Hardware revision

Malignant bone

Soft tissue

Rare

Benign soft tissue or bone

Acute fractures

Infection

Pathologic fractures

Malignant tumors with window for care (eg, RT, chemotherapy)

Pediatric orthopedics

Elective spine deformity

Hip/LE surgery for CP, neuromuscular

LE osteotomies

Clubfoot revisions

Some fractures can be delayed 7–10 d

Elective LE and foot deformity surgery (ambulatory surgery only)

Arthroscopy/peds sports

Clubfoot tenotomy

SCFE from ED

Fracture fixation or casting

Septic arthritis/osteomyelitis/abscess

Spine trauma requiring fixation

Orthopedic sports med

Knee

Arthroscopic meniscectomy, debridement, microfracture, plica excision

ACL reconstruction

Shoulder

Arthroscopic debridement, degenerative rotator cuff repair, biceps tenodesis/tenotomy, slap repair, subacromial decompression, distal clavicle excision

Hip

Arthroscopic hip surgery

Elbow

Arthroscopic and open elbow surgery (excluding fracture/dislocation)

Should be done within 7–14 d:

Acute shoulder instability

Patella instability with osteochondral fragment

Acute displaced/unstable chondral fragment

Closed fracture fixation

Subacute/chronic periprosthetic joint infection without systemic symptoms (ie, sepsis)

Acute rotator cuff tear

Surgery that would result in loss of athletic season if not performed

Major tendon/ligament tear

Pectoralis

Biceps

Achilles

Quad/patella

Hamstring

Triceps

Collateral ligament repair

ACL repair

Elective LE and foot deformity surgery (ambulatory surgery only)

Arthroscopy/peds sports

Clubfoot tenotomy

Irreducible dislocations/unstable dislocations

Native or prosthetic

Septic joint

Infection

Native or surgical site

Open fracture

ACL with bucket handle meniscal tear

Displaced bucket handle meniscal tear

Periprosthetic fracture fixation

Acute periprosthetic joint infection

Subacute/chronic periprosthetic joint infection with systemic symptoms, ie, sepsis

Fractures with neurovascular compromise

Locked elbow or knee

Current matched fresh allografts

Arthroplasty

SNF bound

Elective inpatient

Primary and revision

Same as level 2 except for severe limitation, pain, or immobility

Outpatient healthy total joint arthroplasty

Fractures, acute prosthetic joint infection

Dislocations of a joint

Other emergent, urgent

Urology

Reconstructive surgery for transplant clearance

PCNL for asymptomatic stone without tubes

Pelvic floor repairs

Fistula case

Benign urinary diversion

Bladder diverticulum

Outlet reduction procedure

Penile prosthesis

AUS

Penile plication

Hidden penis repair

TURP/PVP

Excision of benign adrenal tumor

Bladder and bowel reconstruction: bladder augment, bladder catheterizable channel, cecal catheterizable channel, ureteral reimplant

Excision of malignant mass (prostate, kidney, bladder, testis, and penis)

Excision of benign mass affecting health

PCNL for symptomatic stones or drainage tubes in place

Ureteroscopy for symptomatic stones or drainage tubes in place

Pyeloplasty

Urethroplasty

Ileal ureter

Ureterolysis

Pediatric benign nephrectomy

Inguinal orchiectomy

TURBT

Ureteroscopy for asymptomatic stone without tubes

Ureteral stent change

Minor pelvic floor repairs

Anti-incontinence procedures

Sacral neuromodulation

Cysto/RUG/SPT

ProAct placement

Male sling placement

DVIU/urethral dilation

Excision/ablation condyloma

UroLift

Penile abnormality surgery (circumcision, penile adhesion, hypospadias)

Inguinal hernia

Undescended testis

Testicular torsion

Urinary tract infections associated with obstruction

Acute urinary tract obstruction associated with decline in renal function

Priapism

Fournier’s gangrene

Cystoscopy with clot evacuation

Explant infected prosthetic device

Pediatric malignancy not testis

Pain medicine

Minimally invasive pain procedures, implants, and percutaneous interventions

Elderly (older than 75 y)

Steroid injections for patients with comorbidities (postpulmonary/cardiac transplant, COPD with O2 dependency, uncontrolled diabetes)

-Hospitalized patients: percutaneous pain interventions/minimally invasive pain procedures/implants to facility hospital discharge.

Outpatient: emergency/complications (eg, infection) of implant

Interventional radiologyVisceral

Varicose veins

Hydrocele sclerotherapy

TIPS revision: ascites

Vertebral augmentation

Embo: gonadal vein

Nerve injections

Embo: fibroid

IVC filter removal

CVL/port removal (completion of therapy)

Feeding tube exchange (routine)

Peds

VCUGs

Renograms

Barium GI series for chronic conditions

MSK

Imaging-guided soft tissue (trigger point) injection

Neuro/spine

Sclerotherapy and Botox injections

Visceral

Embo: fibroid

Visceral

Transjugular liver biopsy

PTHD (low acuity)

PCN: new (low acuity)

TIPS placement: ascites (possibly >14 d)

Percutaneous ablation (possibly >14 d)

Embo: pulmonary AVM (possibly >14 d)

TIPS revision: bleeding

Body

Native kidney biopsy

Lung mass biopsy

Abdominal mass high-risk biopsy

Neuro/spine

Multilevel blood patch

Multistaged sclerotherapy

Visceral

Embo: gonadal vein, liver – tumor (TAE/TARE)

Dialysis procedures

Varicose veins

Hydrocele sclerotherapy

IVC filter placement/removal

Cholangiogram

Feeding tube placement/change

Tunneled ascites catheter

Catheter/CVL exchange or removal (any)

Port/tunneled CVL placement

Vertebral augmentation, nerve injections

TIPS revision: ascites

Body

Breast mass biopsy

Thyroid FNA

Lymph node biopsy

Paracentesis/thora

Seroma/superficial abscess drainage

Low-risk abdominal mass or soft tissue biopsy

Neuro/spine

LPs/Myelograms

FNA/biopsies of head, neck, or spine

Sclerotherapy and Botox injections

MSK

Arthrocentesis

Imaging-guided biopsy

Imaging-guided soft tissue (trigger point) injection

Visceral

PTHD (high acuity)

PCN: new (high acuity)

Embo—any hemorrhage

Thrombolysis

TIPS placement: history of bleeding

Body

Abdominal/pelvic abscess drainage

Empyema

Peds

Intussusception reduction

Barium study for malrotation

Ophthalmology

Cataracts that impact legal driving standards

Conjunctival or corneal neoplasm

Pediatric cataracts

Advanced TRD in monocular patient

Cataracts >12 year old

Blepharoplasty

Chalazion

Ectropion/entropion repair

Nasal lacrimal duct probing

Macular hole

PPV/ERM peel

Strabismus >10 year old

Mild/moderate glaucoma with >135 degrees of binocular field

PTK/Lasik/PRK

Routine transplants

Pterygium surgery

Globe rupture

Endophthalmitis

Bilateral vitreous hemorrhage

Emergency transplant

Perforated ulcer

Eyelid malignancy excision/repair

Vitreous biopsy/FNA of choroidal mass

Rhegmatogenous RD

Advanced or neovascular glaucoma

Hyphema with high IOP

ROP

Phacomorphic angle closure

Intraocular foreign body

Intraocular tumor

AAA, abdominal aortic aneurysm; ACDF, anterior cervical discectomy and fusion; ACHD, adult congenital heart disease; ACL, anterior cruciate ligament; AIN, anal intraepithelial neoplasia; ASD, atrial septal defect; AUS, artificial urinary sphincter; AVM, arteriovenous malformation; CABG, coronary artery bypass graft; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; COVID-19, 2019 novel coronavirus; CP, cerebral palsy; CSF, cerebral spinal fluid; CV, cardiovascular; CVL, central venous line; DBS, deep brain stimulation; DVIU, direct vision internal urethrotomy; ECMO, extracorporal membrane oxygenation; ECT, electroconvulsive therapy; EEG, electroencephalogram; EGD, esophagogastroduodenoscopy; EP, electrophysiology; EPS, electrophysiology studies; ERM, epiretinal membrane; FNA, fine needle aspiration; GI, gastrointestinal; ICD, implantable cardioverter defibrillator; ICH, intracerebral hemorrhage; ICU, intensive care unit; IOP, intraocular pressure; IVC, inferior vena cava; LE, lower extremity; LP, lumbar puncture; MELD, model for end-stage liver disease; MI, myocardial infarction; MSK, muskuloskeletal; MVD, microvascular decompression; N/A, not applicable; PAPVR, partial anomalous pulmonary venous return; PCN, percutaneous nephrostomy; PCNL, percutaneous nephrolithotomy; PEG, percutaneous endoscopic gastrostomy; PPE, personal protective equipment; PPV, pars plana vitrectomy; PRK, photorefractive keratectomy; PTHD, percutaneous transhepatic biliary drainage; PTK, phototherapeutic keratectomy; PVP, photo-vaporization of prostate; RD, retinal detachment; RNS, responsive neurostimulation for seizures; ROP, retinopathy of prematurity; RT, radiation therapy; SNF, skilled nursing facility; SPT, suprapubic tube; SVT, supraventricular tachycardia; TAAAA, thoracoabdominal aortic aneurysm; TAVR, transcatheter aortic valve replacement; TEVAR, thoracic endovascular aortic repair; TIPS, transjugular intrahepatic portosystemic shunt; TRD, tractional retinal detachment; TURBT, transurethral resection of bladder tumor; TURP, transurethral resection of prostate; TVICU, thoracic/vascular intensive care unit; VAD, ventricular assist device; VCUG, voiding cystourethrogram; VP, ventriculoperitoneal; VSD, ventriculoseptal defect.

Weber LeBrun. COVID-19 pandemic: staged management of surgical services for gynecology and obstetrics. Am J Obstet Gynecol 2020.

  9 in total

1.  Cancellation of scheduled procedures as a mechanism to generate hospital bed surge capacity-a pilot study.

Authors:  Olan A Soremekun; Richard D Zane; Andrew Walls; Matthew B Allen; Kimberly J Seefeld; Daniel J Pallin
Journal:  Prehosp Disaster Med       Date:  2011-06       Impact factor: 2.040

2.  The dwindling supply of empty beds: implications for hospital surge capacity.

Authors:  Derek DeLia; Elizabeth Wood
Journal:  Health Aff (Millwood)       Date:  2008 Nov-Dec       Impact factor: 6.301

3.  Hospital emergency surge capacity: an empiric New York statewide study.

Authors:  Robert K Kanter; John R Moran
Journal:  Ann Emerg Med       Date:  2006-12-18       Impact factor: 5.721

4.  Hospital Disaster Preparedness in Italy: a preliminary study utilizing the World Health Organization Hospital Emergency Response Evaluation Toolkit.

Authors:  Pier L Ingrassia; Marco Mangini; Massimo Azzaretto; Ilenia Ciaramitaro; Laura Costa; Frederick M Burkle; Francesco Della Corte; Ahmadreza Djalali
Journal:  Minerva Anestesiol       Date:  2016-06-07       Impact factor: 3.051

5.  Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response.

Authors:  Giacomo Grasselli; Antonio Pesenti; Maurizio Cecconi
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

6.  Creation of surge capacity by early discharge of hospitalized patients at low risk for untoward events.

Authors:  Gabor D Kelen; Melissa L McCarthy; Chadd K Kraus; Ru Ding; Edbert B Hsu; Guohua Li; Judy B Shahan; James J Scheulen; Gary B Green
Journal:  Disaster Med Public Health Prep       Date:  2009-06       Impact factor: 1.385

Review 7.  Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know.

Authors:  Sonja A Rasmussen; John C Smulian; John A Lednicky; Tony S Wen; Denise J Jamieson
Journal:  Am J Obstet Gynecol       Date:  2020-02-24       Impact factor: 8.661

8.  The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

Authors:  Noah C Peeri; Nistha Shrestha; Md Siddikur Rahman; Rafdzah Zaki; Zhengqi Tan; Saana Bibi; Mahdi Baghbanzadeh; Nasrin Aghamohammadi; Wenyi Zhang; Ubydul Haque
Journal:  Int J Epidemiol       Date:  2020-06-01       Impact factor: 7.196

9.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  9 in total
  7 in total

1.  Challenges in the Practice of Sexual Medicine in the Time of COVID-19 in the United States.

Authors:  Alan W Shindel; Tami S Rowen
Journal:  J Sex Med       Date:  2020-05-23       Impact factor: 3.802

2.  Joint Statement on Re-introduction of Hospital and Office-based Procedures for the Practicing Urogynecologist and Gynecologist.

Authors: 
Journal:  J Minim Invasive Gynecol       Date:  2020-05-27       Impact factor: 4.137

3.  Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?

Authors:  Roger Pique-Regi; Roberto Romero; Adi L Tarca; Francesca Luca; Yi Xu; Adnan Alazizi; Yaozhu Leng; Chaur-Dong Hsu; Nardhy Gomez-Lopez
Journal:  Elife       Date:  2020-07-14       Impact factor: 8.140

Review 4.  A guide for urogynecologic patient care utilizing telemedicine during the COVID-19 pandemic: review of existing evidence.

Authors:  Cara L Grimes; Ethan M Balk; Catrina C Crisp; Danielle D Antosh; Miles Murphy; Gabriela E Halder; Peter C Jeppson; Emily E Weber LeBrun; Sonali Raman; Shunaha Kim-Fine; Cheryl Iglesia; Alexis A Dieter; Ladin Yurteri-Kaplan; Gaelen Adam; Kate V Meriwether
Journal:  Int Urogynecol J       Date:  2020-04-27       Impact factor: 2.894

5.  Perioperative SARS-CoV-2 infection among women undergoing major gynecologic cancer surgery in the COVID-19 era: A nationwide, cohort study from Turkey.

Authors:  Ali Ayhan; Murat Oz; Nazli Topfedaisi Ozkan; Koray Aslan; Müfide Iclal Altintas; Hüseyin Akilli; Erdal Demirtas; Osman Celik; Mustafa Mahir Ülgü; Suayip Birinci; Mehmet Mutlu Meydanli
Journal:  Gynecol Oncol       Date:  2020-11-17       Impact factor: 5.482

Review 6.  Adapting obstetric and neonatal services during the COVID-19 pandemic: a scoping review.

Authors:  Shira Gold; Lauren Clarfield; Jennie Johnstone; Yenge Diambomba; Prakesh S Shah; Wendy Whittle; Nimrah Abbasi; Cristian Arzola; Rizwana Ashraf; Anne Biringer; David Chitayat; Marie Czikk; Milena Forte; Tracy Franklin; Michelle Jacobson; Johannes Keunen; John Kingdom; Stephen Lapinsky; Joanne MacKenzie; Cynthia Maxwell; Mary Preisman; Greg Ryan; Amanda Selk; Mathew Sermer; Candice Silversides; John Snelgrove; Nancy Watts; Beverly Young; Charmaine De Castro; Rohan D'Souza
Journal:  BMC Pregnancy Childbirth       Date:  2022-02-11       Impact factor: 3.007

7.  Management of gynecology patients during the coronavirus disease 2019 pandemic: Chinese expert consensus.

Authors:  Lin Qiu; Abraham Morse; Wen Di; Lei Song; Beihua Kong; Zehua Wang; Jinghe Lang; Wenzhao Chai; Lan Zhu
Journal:  Am J Obstet Gynecol       Date:  2020-05-15       Impact factor: 8.661

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.